The Art of Breaking Bad News

Ask a number of people how they received unsettling news about their cancer and most will remember in striking detail, but a doctor-led program aims to help physicians learn how to break bad news better. Will it help?
At the age of 38, Lesley Andrews found herself in a breast surgeon’s office. She wasn’t too worried about the lump in her breast, assuming it was like the one she’d found three years earlier, which was benign.

After an examination and an ultrasound, the doctor took her into his office, sat behind the desk and said, “I don’t like the shape of this one.”

“My stomach dropped, and I got very upset and anxious,” Andrews says. “I was looking to him for guidance, but he wouldn’t look at me. He kept checking his beeper and wouldn’t answer my questions. Finally, he told me to go to the front desk to make an appointment for a biopsy. As I left, he said, ‘Have a nice day.’”

Ask any number of people how their doctors broke the news of a cancer diagnosis, recurrence or progression, and most will remember in striking detail. Yet, despite the numerous times the situation arises and its impact on patients, many doctors are not skilled at breaking bad news.

[At Diagnosis: Dealing with Emotions]

Studies reveal that gender, age and education can influence how an individual prefers to receive bad news. Some patients want to know everything; others can only take in so much. Some patients prefer receiving bad news over the phone in lieu of waiting for an in-person appointment, while others prefer face-to-face discussion.

Whatever the patient’s preference, the medical community recognizes it is the doctor’s responsibility to deliver information and support in a way that doesn’t harm the patient. More than a decade ago, an article published in The Oncologist developed a six-step protocol, known as SPIKES, to offer guidance to clinicians breaking bad news to patients with cancer.

The problem is that not many doctors are trained in this pivotal area, and a comforting bedside manner may not come naturally to some in the medical profession.

A neonatologist who works with parents of high-risk newborns, Anthony J. Orsini became passionately interested in the art of breaking bad news well over 15 years ago. He believes it’s a skill that can be taught, and wants patients and their families to know they have a right to expect their doctors to be good at it.

Recognizing that physicians and healthcare workers are “afraid to deliver bad news, and they don’t get enough guidance and training to go about it,” Orsini developed the Breaking Bad News (BBN) Model.

The BBN Model has three parts:

1. A scenario is provided in which professional, improvisational actors portray patients or family members to whom the participant must break bad news.

2. The role-playing sessions are filmed and watched remotely by BBN-certified instructors.

3. Immediately after the role-playing session, the participant watches the video and reviews and reflects on his or her performance with input from the instructors.

Specific attention is paid to body language and speech that communicates compassion and optimizes information flow. Participants learn how to prepare for the session, sit with the patient, lean in, make eye contact, and truly listen and react to the patient and family members.

Talk about this article with other patients, caregivers, and advocates in the General Discussions CURE discussion group.
Special Feature
Share Your Art
Related Articles
The Logistics of Multigene Panel Testing in Breast Cancer
Generally, health insurance covers the cost of genetic testing recommended by a physician. However, some patients who had BRCA testing in the past have had trouble getting reimbursed for a follow-up panel test. The outof- pocket cost for a single panel test can be up to $5,000, although lower-cost tests are available.
Young Patients With Cancer Don't Always Get the Info They Need
When treated for cancer, young patients don’t always get the information they need from doctors.
Immunotherapy Offers New Optimism for Patients With Merkel Cell Carcinoma
Although chemotherapy has been used to treat patients with Merkel cell carcinoma, immunotherapy agents show great promise, according to findings presented at the 2017 World Congress of Melanoma.
Related Videos
Preserving Eyebrows During Chemotherapy Treatment
Renata Marie Vestevich, founder and developer of Essential Eyebrow Solution (EES), discusses how this topical solution may be able to help patients keep their eyebrow hair while undergoing chemotherapy.
Does Age Affect Cancer Genomics?
Garrett Frampton, associate director of Cancer Genomics at Foundation Medicine, discusses recent research about genetic mutations that are more common in certain age groups.  
Facing Advanced Cancer's Struggles With CALM
Gary Rodin, M.D., head of the Department of Supportive Care at Princess Margaret Cancer Centre, in Toronto, Canada, discusses CALM, an intervention designed to help patients with advanced-stage cancer cope and talk about their concerns.
//For side ad protocol